STOCK TITAN

Iridex to Host Third Quarter Financial Results Conference Call on November 14, 2023

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
IRIDEX Corporation (NASDAQ: IRIX) announced plans to host its third quarter financial results conference call on November 14, 2023, and participate in the upcoming Stifel Healthcare Conference on November 15, 2023. The Company specializes in ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases.
Positive
  • None.
Negative
  • None.

The Company also announced plans to present at Stifel Healthcare Conference

MOUNTAIN VIEW, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced the Company will host its third quarter financial results conference call on November 14, 2023 and plans to participate in the upcoming Stifel Healthcare Conference on November 15, 2023 in New York, NY.

Third Quarter Earnings Conference Call
The Company’s management team will host a conference to discuss reported financial results and business updates beginning at 2:00 p.m. PT / 5:00 p.m. ET on November 14, 2023.

Stifel 2023 Healthcare Conference
Management is scheduled to present on Wednesday, November 15 at 10:20 a.m. ET.

Investors interested in listening to the conference call and presentation may do so by accessing the live and recorded webcasts on the “Event Calendar” page of the “Investors” section of the Company’s website at: www.iridex.com.

About Iridex
Iridex Corporation is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. The Company’s proprietary MicroPulse® technology delivers a differentiated treatment that provides safe, effective, and proven treatment for targeted sight-threatening eye conditions. Iridex’s current product line is used for the treatment of glaucoma and diabetic macular edema (DME) and other retinal diseases. Iridex products are sold in the United States through a direct sales force and internationally primarily through a network of independent distributors into more than 100 countries. For further information, visit the Iridex website at www.iridex.com.

Investor Relations Contact:
Philip Taylor
Gilmartin Group
investors@iridex.com

 


FAQ

When is IRIDEX Corporation hosting its third quarter financial results conference call?

The conference call is scheduled for November 14, 2023, at 2:00 p.m. PT / 5:00 p.m. ET.

When is IRIDEX Corporation participating in the Stifel Healthcare Conference?

The Company is scheduled to present at the Stifel Healthcare Conference on November 15, 2023, at 10:20 a.m. ET.

Where can investors access the live and recorded webcasts of the conference call and presentation?

Investors can access the webcasts on the 'Event Calendar' page of the 'Investors' section of IRIDEX Corporation's website at www.iridex.com.

IRIDEX Corporation

NASDAQ:IRIX

IRIX Rankings

IRIX Latest News

IRIX Stock Data

39.82M
12.27M
25%
20.13%
1.97%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
MOUNTAIN VIEW

About IRIX

iridex corporation, founded in 1989, is a worldwide leader in developing, manufacturing, and marketing innovative and versatile light-based medical systems and delivery devices. we offer laser based solutions for multiple specialties including aesthetic medicine, ophthalmology, and otolaryngology. we also maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. with superior technology for superior results, iridex is dedicated to standards of excellence that meet your own.